Navigation Links
Bionovo Announces Third Quarter 2011 Highlights and Financial Results
Date:11/10/2011

," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.Financial Tables on Following PagesBionovo, Inc.(A Development Stage Company)Condensed Consolidated Statements of Operations(Unaudited, in thousands, except per share amounts)Three months ended
September 30,Nine months ended
September 30,Accumulated
from February
1, 2002 (Date of
inception) to
September 30,20112010201120102011Revenues

$
49 $
8 $
214 $
82 $
2,007 Operating expenses:Research and development

5,6093,67314,99910,80769,347General and administrative

7699872,6942,62723,822Merger cost

----1,964Total operating expenses

6,3784,66017,69313,43495,133Loss from operations

(6,229)(4,592)(17,479)(13,352)(93,126)Other income (expense):Change in fair value of warrant liability

2,316-4,017-4,753Interest income

6224162,116Interest expense

(24)(9)(77)(33)(599)Other income (expen
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
2. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
3. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
4. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
6. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
7. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
8. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
9. Bionovo Announces 2010 Highlights and Year-End Financial Results
10. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
11. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... CHICAGO, Ill., July 25, 2014 NOT ... DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE ... LAWS OR REGULATIONS OF SUCH JURISDICTION AbbVie (NYSE: ... ended June 30, 2014. "This was another ... earnings per share above our original guidance and announced plans ...
(Date:7/24/2014)... July 24, 2014   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ... on the development and commercialization of innovative therapies for ... the PDUFA date for Zalviso remains July 27, 2014.  ... circulated online stating the Food and Drug Administration (FDA) ... has been no notification to the company from the ...
(Date:7/24/2014)... 24, 2014  Restore Health, a leading personalized ... announced that it is now offering pharmacogenetics testing ... individual based upon their particular genetic makeup. Comprehensive ... interaction between a patient,s genetics and their entire ... to provide this new service to healthcare providers ...
Breaking Medicine Technology:AbbVie Reports Second-Quarter 2014 Financial Results 2AbbVie Reports Second-Quarter 2014 Financial Results 3AbbVie Reports Second-Quarter 2014 Financial Results 4AbbVie Reports Second-Quarter 2014 Financial Results 5AbbVie Reports Second-Quarter 2014 Financial Results 6AbbVie Reports Second-Quarter 2014 Financial Results 7AbbVie Reports Second-Quarter 2014 Financial Results 8AbbVie Reports Second-Quarter 2014 Financial Results 9AbbVie Reports Second-Quarter 2014 Financial Results 10AbbVie Reports Second-Quarter 2014 Financial Results 11AbbVie Reports Second-Quarter 2014 Financial Results 12AbbVie Reports Second-Quarter 2014 Financial Results 13AbbVie Reports Second-Quarter 2014 Financial Results 14AbbVie Reports Second-Quarter 2014 Financial Results 15AbbVie Reports Second-Quarter 2014 Financial Results 16AbbVie Reports Second-Quarter 2014 Financial Results 17AbbVie Reports Second-Quarter 2014 Financial Results 18AbbVie Reports Second-Quarter 2014 Financial Results 19AbbVie Reports Second-Quarter 2014 Financial Results 20AbbVie Reports Second-Quarter 2014 Financial Results 21AbbVie Reports Second-Quarter 2014 Financial Results 22AbbVie Reports Second-Quarter 2014 Financial Results 23AbbVie Reports Second-Quarter 2014 Financial Results 24AbbVie Reports Second-Quarter 2014 Financial Results 25AbbVie Reports Second-Quarter 2014 Financial Results 26AbbVie Reports Second-Quarter 2014 Financial Results 27AbbVie Reports Second-Quarter 2014 Financial Results 28AbbVie Reports Second-Quarter 2014 Financial Results 29AbbVie Reports Second-Quarter 2014 Financial Results 30AbbVie Reports Second-Quarter 2014 Financial Results 31AbbVie Reports Second-Quarter 2014 Financial Results 32AbbVie Reports Second-Quarter 2014 Financial Results 33AbbVie Reports Second-Quarter 2014 Financial Results 34AbbVie Reports Second-Quarter 2014 Financial Results 35AbbVie Reports Second-Quarter 2014 Financial Results 36
(Date:7/25/2014)... 2014 Sport Court® provided ... Nike National Invitational Tournament (NIT) in Chicago ... Junior National Tournament (USJN) in Washington D.C. at ... for these prestigious national tournaments included 44 Sport Court ... of playing surface at McCormick Place for the NIT, ...
(Date:7/25/2014)... by People Magazine in the article Mike 'The Situation' ... (7/15), one of the most popular cast stars from MTV's ... about his personal transformation. Now, two years later since the ... with his life was a challenge. He was previously addicted ... even spent some time in rehab. He took the opportunity ...
(Date:7/25/2014)... 25, 2014 (HealthDay News) -- The human brain can ... dehydration, a new study finds. Although dehydration ... England have found that the brain compensates by increasing ... "This research has helped us understand a lot ... exercise in extreme conditions," study first author Steven Trangmar, ...
(Date:7/25/2014)... Art of Facial Surgery has recently stepped ... Toronto who are looking for minor touch-ups to make them ... the American Academy of Facial Plastic and Reconstructive Surgery ... plastic surgery showed a surprising increase between 2012 and 2013. ... hair transplants increased by 7 percent and eyelid surgery increased ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 A new study ... results of which are published today in Cancer , ... 55 and 74 who had an abnormal finding on a ... reduced quality of life than did those who were screened ... as a surprise to the researchers. “We expected that participants ...
Breaking Medicine News(10 mins):Health News:Sport Court Provides All Sports Flooring for Basketball Events in Chicago and Washington D.C. 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 2Health News:Art of Facial Surgery Responds to Demand for Facial Plastic Surgery Increase Due to the Popularity of Selfies 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5
... help treat bone metastases in patients with lung cancer could ... prevent the cancer from spreading in the first place, Italian ... the Catholic University of the Sacred Heart in Rome have ... to prevent lung cancer metastases from recruiting the new blood ...
... HealthDay Reporter , THURSDAY, Feb. 24 (HealthDay News) -- While ... scourge of centuries past, isolated cases still appear, even in ... government report, a American lab worker died from plague in ... infection since 1959 and the first known death from a ...
... Sloan-Kettering Cancer Center have found that change in PSA levels ... poor predictor of prostate cancer and may lead to many ... was published online February 24 in the Journal of ... Research Methodologist in the Department of Epidemiology and Biostatistics and ...
... Montreal, February 24, 2011 The interventional cardiology team ... enrolment for a new device, the Neovasc ReducerTM, designed ... method is a first in North America and is ... COSIRA trial. This innovative treatment is promising for thousands ...
... HealthDay Reporter , THURSDAY, Feb. 24 (HealthDay News) -- Preliminary ... patients and may stave off progression of the AIDS-causing virus. ... this purpose, the findings of this small study raise the ... the immune response in HIV patients whether they,re taking AIDS ...
... LANSING, Mich. Michigan State University has secured ... food security in Mozambique through increasing the African ... nutrition. The four-year grant, funded by the ... MSU and the University of Florida. The initiative ...
Cached Medicine News:Health News:Bone drug zoledronic acid may help prevent spread of early lung cancer 2Health News:Plague Kills U.S. Lab Worker 2Health News:Plague Kills U.S. Lab Worker 3Health News:Change in PSA level does not predict prostate cancer 2Health News:A North American first at the Montreal Heart Institute could help treat thousands of Canadians 2Health News:Statins Might Help HIV Patients, Study Suggests 2Health News:$7.9 million grant to improve food security, nutrition in Mozambique 2
Inquire...
Inquire...
Hydragel K20 is Sebia's quality line of manual agarose gel electrophoresis products. Samples are applied utilizing the same patented applicator combs that is used for sample application on the HYDRAS...
... EXTENDER® is a new device for skin ... silicone elastomer strips, it allows a constant ... well beyond other devices capacities. Such effectiveness ... implant since it is removed before 30 ...
Medicine Products: